News


Published Wednesday, December 28, 2016

ClearPath DS-120 Customers who have purchased the device prior to November 2016, please note: for any warranty / service related issues, or technical queries, please use the following contact information: Email: ClearPathDS120@gmail.com Phone: +1 (858) 86 DS120 (+1 - 858 863 7120)



Published Wednesday, May 27, 2015

SAN DIEGO – May 28, 2015—Freedom Meditech, Inc., a medical device company transforming the diagnosis and monitoring of chronic diseases from current blood-based standards to early and non-invasive detection, today announced that the company has raised $4.8 million in a Series C financing. The company seeks to raise additional capital and has more»



Published Friday, May 15, 2015

Despite effective prevention and treatment, the twin epidemics of diabetes and diabetic retinopathy (DR) continue to flourish throughout most of the world. 

more»



Published Wednesday, February 12, 2014

SAN DIEGO, February 12, 2014 — Freedom Meditech today announced the publication of a study comparing measurement of lens autofluorescence to current hemoglobin A1c and fasting plasma glucose tests.

more»



Published Friday, January 10, 2014

SAN DIEGO, CA (January 9, 2014) — Freedom Meditech, Inc. today announced that it has completed registration activities required to apply the CE Mark under the European Union (EU) Medical Device Directives (MDD) and has received a Canadian Device Establishment License in Canada for the ClearPath DS-120. The ClearPath DS-120 is a first-in-class, more»



Published Wednesday, October 30, 2013

SAN DIEGO, October 30, 2013 —Freedom Meditech, Inc. has announced that the company has been invited to present a live demonstration of the ClearPath DS-120™ at the 13th Annual Diabetes Technology Meeting, the premier event in the United States for showcasing latest technological advances for people with diabetes. Cleared by the U.S. Food and more»



Published Tuesday, August 6, 2013

San Diego, CA, August 1, 2013 — Freedom Meditech today announced that it has closed a $7 million Series B financing. Funds will support the U.S. commercial launch of the ClearPath DS-120™ Lens Fluorescence Biomicroscope which was cleared by the U.S. Food and Drug Administration (FDA) earlier this year.

more»



Published Wednesday, June 26, 2013

SAN DIEGO – June 26, 2013Freedom Meditech, Inc., developer of non-invasive ophthalmic products for the detection of disease and management of patient health, has launched the ClearPath DS-120™ Lens Fluorescence Biomicroscope.

more»



Published Wednesday, June 12, 2013

SAN DIEGO -- June 12, 2013 -- Freedom Meditech, Inc., a medical device company commercializing non- invasive ophthalmic technologies for the detection of disease and management of patient health, today announced the appointment of Paul M. Karpecki, OD, FAAO, to the Scientific Advisory Board.

more»



Published Tuesday, February 12, 2013

SAN DIEGO, CA (February 12, 2013) – Freedom Meditech, Inc., developer of non-invasive ophthalmic products for the detection of disease and management of patient health, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell its first product, the ClearPath DS-120TM Lens Fluorescence Biomicroscope.

more»


Items 1-10 of 32